Загрузка...
Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum β-Lactamase Bacteremia
Background. The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of extended-spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day mortality of PTZ vs carbapenems as empiric therapy in a cohort of patients with ESBL bacteremia who all received definitive therapy...
Сохранить в:
| Опубликовано в: : | Clin Infect Dis |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4462658/ https://ncbi.nlm.nih.gov/pubmed/25586681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|